Correlation Between Agilent Technologies and Royalty Pharma
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and Royalty Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and Royalty Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and Royalty Pharma Plc, you can compare the effects of market volatilities on Agilent Technologies and Royalty Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of Royalty Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and Royalty Pharma.
Diversification Opportunities for Agilent Technologies and Royalty Pharma
0.63 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Agilent and Royalty is 0.63. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and Royalty Pharma Plc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Royalty Pharma Plc and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with Royalty Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Royalty Pharma Plc has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and Royalty Pharma go up and down completely randomly.
Pair Corralation between Agilent Technologies and Royalty Pharma
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 1.87 times more return on investment than Royalty Pharma. However, Agilent Technologies is 1.87 times more volatile than Royalty Pharma Plc. It trades about 0.12 of its potential returns per unit of risk. Royalty Pharma Plc is currently generating about -0.05 per unit of risk. If you would invest 13,149 in Agilent Technologies on August 31, 2024 and sell it today you would earn a total of 665.00 from holding Agilent Technologies or generate 5.06% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. Royalty Pharma Plc
Performance |
| Timeline |
| Agilent Technologies |
| Royalty Pharma Plc |
Agilent Technologies and Royalty Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and Royalty Pharma
The main advantage of trading using opposite Agilent Technologies and Royalty Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, Royalty Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Royalty Pharma will offset losses from the drop in Royalty Pharma's long position.| Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. IQVIA Holdings | Agilent Technologies vs. Charles River Laboratories | Agilent Technologies vs. Revvity |
| Royalty Pharma vs. Prime Medicine, Common | Royalty Pharma vs. Ginkgo Bioworks Holdings | Royalty Pharma vs. Ocean Biomedical | Royalty Pharma vs. Adaptive Biotechnologies Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Anywhere Track or share privately all of your investments from the convenience of any device | |
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Insider Screener Find insiders across different sectors to evaluate their impact on performance | |
| Global Correlations Find global opportunities by holding instruments from different markets | |
| Equity Valuation Check real value of public entities based on technical and fundamental data |